[{"address1": "3950 South Country Club Road", "address2": "Suite 470 4th Floor", "city": "Tucson", "state": "AZ", "zip": "85714", "country": "United States", "phone": "520 365 3100", "website": "https://acceleratediagnostics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.", "fullTimeEmployees": 134, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jack  Phillips", "age": 57, "title": "CEO, President & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 595000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Patience", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 285272, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lawrence Michael Mertz", "age": 60, "title": "Chief Technology Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 335939, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maya  Gowri", "title": "Senior VP & Head of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Laura  Pierson", "title": "Investor Relations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Meduri", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chris  Thode", "title": "Senior Vice President of US Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rita  Boukamel", "title": "Senior VP & Head of EMEA", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1724803200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.91, "open": 1.91, "dayLow": 1.78, "dayHigh": 2.0399, "regularMarketPreviousClose": 1.91, "regularMarketOpen": 1.91, "regularMarketDayLow": 1.78, "regularMarketDayHigh": 2.0399, "beta": 0.574, "forwardPE": -1.1688304, "volume": 129444, "regularMarketVolume": 129444, "averageVolume": 51449, "averageVolume10days": 48260, "averageDailyVolume10Day": 48260, "bid": 1.95, "ask": 2.04, "bidSize": 100, "askSize": 100, "marketCap": 47328016, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 7.06, "priceToSalesTrailing12Months": 3.8688805, "fiftyDayAverage": 1.391, "twoHundredDayAverage": 1.8513, "currency": "USD", "enterpriseValue": 79991984, "floatShares": 12262368, "sharesOutstanding": 23679400, "sharesShort": 551138, "sharesShortPriorMonth": 607651, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0233, "heldPercentInsiders": 0.40689, "heldPercentInstitutions": 0.18035, "shortRatio": 10.61, "shortPercentOfFloat": 0.0356, "impliedSharesOutstanding": 23679400, "bookValue": -1.473, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -37906000, "trailingEps": -1.35, "forwardEps": -1.71, "pegRatio": -0.03, "lastSplitFactor": "1:10", "lastSplitDate": 1689120000, "enterpriseToRevenue": 6.539, "enterpriseToEbitda": -1.962, "52WeekChange": -0.70972425, "SandP52WeekChange": 0.2560848, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "AXDX", "underlyingSymbol": "AXDX", "shortName": "Accelerate Diagnostics, Inc.", "longName": "Accelerate Diagnostics, Inc.", "firstTradeDateEpochUtc": 765725400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a602e4de-ddad-3ecf-864d-d40f7da91eac", "messageBoardId": "finmb_363801", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.9987, "targetHighPrice": 1.5, "targetLowPrice": 1.5, "targetMeanPrice": 1.5, "targetMedianPrice": 1.5, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 9746000, "totalCashPerShare": 0.412, "ebitda": -40770000, "totalDebt": 42410000, "quickRatio": 0.897, "currentRatio": 1.28, "totalRevenue": 12233000, "revenuePerShare": 0.665, "returnOnAssets": -0.75851, "freeCashflow": -54674248, "operatingCashflow": -32043000, "revenueGrowth": 0.022, "grossMargins": 0.17485, "operatingMargins": -2.8821201, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]